UniQure Prices Upsized $225 Mln Offering Of Shares At $45.50 Per Share

uniQure priced an upsized public offering of 4.95 million shares at $45.50 per share, implying gross proceeds of approximately $225 million. The transaction is a capital-raising event for the biotech company and is likely modestly dilutive, but the article provides no operational update or other materially new business developments.

Analysis

uniQure priced an upsized public offering of 4.95 million shares at $45.50 per share, implying gross proceeds of approximately $225 million. The transaction is a capital-raising event for the biotech company and is likely modestly dilutive, but the article provides no operational update or other materially new business developments.